1. All Products
  2. D - Drugs
  3. ATV 300mg / r 100mg, tab.
Public Pricelist

ATV 300mg / r 100mg, tab.

https://medicalguidelines.msf.org/en/node/361
https://msf.oodin.sh/cat/product/11903
NST DORAATVR3T-

Outdated Article

Former Code(s): DORAATVR3T1
6.4.2.3 - Protease inhibitors
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AR23
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
https://msf.oodin.sh/web/image/product.template/569022/image_1920?unique=9e02f2a

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

ATAZANAVIR (ATV) / RITONAVIR (r)

Therapeutic Action

Fixed-dose combination (FDC) of two antiretrovirals, protease inhibitors (PI)

Indications

HIV infection

The combination of darunavir / ritonavir is the preferred boosted protease inhibitor option for ART if a protease inhibitor is needed.

Combinations of atazanavir + ritonavir or lopinavir + ritonavir can be used as alternatives if darunavir / ritonavir cannot be used.

Instructions for use

DRV eq. 400mg base / r 50mg, tablet is first choice over ATV 300mg / r 100mg, tablet.

Storage

Below 25ºC